Crick — Clinical Intelligence Platform

Not applicableStudy completedNCT02651246

What this trial is testing

Optional Sub-study to Intraoperative Imaging With ICG Registry

Who this might be right for

Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) CancerCancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma CancerCancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer

Abramson Cancer Center at Penn Medicine 291

Results for “Neoplasm of Head of Pancreas”

Optional Sub-study to Intraoperative Imaging With ICG Registry

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy

In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

DEG6498 in Participants With Solid Tumors

Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6